Profile
Kalavathi Bandi has worked as a Director at Hetero Drugs Ltd.
since 2015 and is currently still employed there.
She also holds a Director position at Hetero Labs Ltd.
Kalavathi Bandi active positions
Companies | Position | Start |
---|---|---|
Hetero Drugs Ltd.
Hetero Drugs Ltd. Pharmaceuticals: MajorHealth Technology Hetero Drugs Ltd. manufactures and markets pharmaceutical ingredients. It manufactures and markets Active Pharmaceutical Ingredients (APIs), intermediate, and finished dosages. The company was founded by Bandi Partha Saradhi Reddy in 1993 and is headquartered in Hyderabad, India. | Director/Board Member | 2015-03-31 |
Hetero Labs Ltd.
Hetero Labs Ltd. Pharmaceuticals: MajorHealth Technology Hetero Labs Ltd. manufactures and supplies active pharmaceutical ingredients. Its products include antihypertensives, amlodipine besylate, doxazosin mesylate, benazepril, irbesartan, acitretin, adefovir dipivoxil and alfuzosin HCL. Hetero Labs was incorporated on March 10, 1989 and is headquartered in Hyderabad, India. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Hetero Drugs Ltd.
Hetero Drugs Ltd. Pharmaceuticals: MajorHealth Technology Hetero Drugs Ltd. manufactures and markets pharmaceutical ingredients. It manufactures and markets Active Pharmaceutical Ingredients (APIs), intermediate, and finished dosages. The company was founded by Bandi Partha Saradhi Reddy in 1993 and is headquartered in Hyderabad, India. | Health Technology |
Hetero Labs Ltd.
Hetero Labs Ltd. Pharmaceuticals: MajorHealth Technology Hetero Labs Ltd. manufactures and supplies active pharmaceutical ingredients. Its products include antihypertensives, amlodipine besylate, doxazosin mesylate, benazepril, irbesartan, acitretin, adefovir dipivoxil and alfuzosin HCL. Hetero Labs was incorporated on March 10, 1989 and is headquartered in Hyderabad, India. | Health Technology |
- Stock Market
- Insiders
- Kalavathi Bandi